Clinical Trial Update: A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH

View source ↗

Summary

This UK multicentre trial evaluated health-related quality of life in children and adolescents with X-Linked Hypophosphataemia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Hypophosphataemia

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: X-Linked Hypophosphataemia | Status: COMPLETED